BeStock  
Stocks › Biotechnology › RIGL

Rigel Pharmaceuticals RIGL

US equityMarket cap rank #3311Biotechnology
$47.99 +$1.88 (+4.08%)
Pre-market · Oct 8, 8:40 am ET · After hours $47.00 -2.06%
Open$45.64
Prev close$46.11
Day range$45.22 – $48.15
Volume232.6K
Market cap$896.45M
P/E (TTM)2.8
Dividend yield–

Earnings

Average move on report day±11.6%last 16 reports
Closed higher11 of 1669% of the time
Best reaction+42.9%
Worst reaction-16.6%

Stock move on the day after each report

+2.2%2023/Q3+5.4%2023/Q4-16.6%2024/Q1+5.8%2024/Q2+42.9%2024/Q3-8.1%2024/Q4+1.2%2025/Q1+23.0%2025/Q2+33.4%2025/Q3-10.3%2025/Q4-5.1%2026/Q1+4.6%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q24 Aug 2026After Market±15.1%+4.60%Within range
2026/Q15 May 2026After Market±17.7%-5.06%Within range
2025/Q43 Mar 2026After Market±19.7%-10.27%Within range
2025/Q34 Nov 2025After Market±16.5%+33.37%Bigger than priced
2025/Q25 Aug 2025After Market±14.2%+22.98%Bigger than priced
2025/Q16 May 2025After Market±9.8%+1.15%Within range
2024/Q44 Mar 2025After Market±15.7%-8.11%Within range
2024/Q37 Nov 2024After Market±22.7%+42.94%Bigger than priced
2024/Q26 Aug 2024After Market±19.3%+5.79%Within range
2024/Q17 May 2024After Market±25.2%-16.61%Within range
2023/Q45 Mar 2024After Market±25.4%+5.41%Within range
2023/Q37 Nov 2023After Market±28.7%+2.24%Within range
2023/Q21 Aug 2023After Market±36.1%-3.01%Within range
2023/Q12 May 2023After Market±26.3%+0.88%Within range
2022/Q47 Mar 2023After Market±40.1%+21.77%Within range
2022/Q33 Nov 2022After Market±41.4%+2.00%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q2, ended Jun 2026

Revenue$78.70M-22.6% YoY
Operating profit$23.58M-61.4% YoY
Net profit$17.29M-71.0% YoY
Diluted EPS$0.88-73.2% YoY
Free cash flow-$39.69M-230.0% YoY
Operating cash flow$30.65M

Revenue, last 8 quarters

$55.3MSep '24$57.6MDec '24$53.3MMar '25$101.7MJun '25$69.5MSep '25$69.8MDec '25$58.8MMar '26$78.7MJun '26

Net profit, last 8 quarters

$12.4MSep '24$14.3MDec '24$11.4MMar '25$59.6MJun '25$27.9MSep '25$268.1MDec '25$8.7MMar '26$17.3MJun '26

Profitability & balance sheet

Gross margin91.4%
Operating margin31.5%
Net margin116.3%
Return on equity126.9%
Return on assets88.5%
Return on invested capital106.1%
Current ratio1.94
Liabilities / assets18.4%
Cash & investments$95.33M
Total debt$39.29M
Net cash (debt)$56.04M
Free cash flow / sales3.3%

Discussion

No comments yet — be the first to weigh in on RIGL.

Leave a comment

Scroll to Top